The Latest: Turkey to receive 3M CoronaVac vaccine doses
|
December 24, 2020 9:30 AM
ISTANBUL — An infectious disease expert serving on Turkey’s medical board says an experimental vaccine developed by Chinese biopharmaceutical company Sinovac showed an efficacy rate of 91,25 percent based on early results of late-stage trials in the country.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
